Table 2.

Clinical data after COVID-19 infection and outcome of treatment strategy in 9 patients with primary immunodeficiency

ID	Age (month)	Sex	PID diagnosis	COVID-19 related symptoms	Treatment strategy	Medication	Outcome/Cause of death
P1	5	F	SCID	Fever, Cough, Dyspnea, Respiratory distress	Hospitalized	IVIG, Acyclovir, Clindamycin, Meropenem, Fluconazole, Steroid	Death/ARDS
P2	32	F	CID-STIM1 deficiency	Fever, Cough, Dyspnea, Respiratory distress, retraction, hypotension , tachypnea	Hospitalized /ICU	IVIG, Vancomycin, Meropenem, Piperacillin/tazobactam, steroid	Death/Sepsis, Cardiorespiratory arrest
P3	18	M	ICF syndrome	Fever	Hospitalized/ ICU	IVIG, Acyclovir, Vancomycin, Piperacillin/tazobactam, steroid	Recovery
P4	124	F	Ataxia-telangiectasia	-	Hospitalized	IVIG,	Recovery
P5	22	M	Bruton agammaglobulinemia	Fever, Cough, Runny nose and sneezing, myalgia	Hospitalized	IVIG, Acyclovir, Vancomycin, Piperacillin/tazobactam, steroid	Recovery
P6	27	M	Bruton agammaglobulinemia	Fever, Cough, Myalgia, Anosmia	No	IVIG, Azithromycin	Recovery
P7	72	F	CVID	Fever, Cough, Dyspnea, GI symptom	Hospitalized	IVIG,	Recovery
P8	480	F	CVID	Fever, Respiratory distress, GI symptom, Anosmia	Hospitalized	IVIG, Meropenem, Tocilizumab, Steroid, Ceftriaxone	Recovery
P9	204	F	Hyper IgE	Fever, Respiratory distress	Hospitalized, ICU	IVIG, Cefixime, Cetirizine	Death/ARDS

PID: Primary immunodeficiency; CID: Combined immunodeficiency; SCID: Severe combined immunodeficiency; ICF: Facial anomalies syndrome; CVID: Common variable immunodeficiency; IVIG: Intravenous immunoglobulin; ARDS: Acute respiratory distress syndrome; P: Patient; M: Male; F: Female